§ 13F · FUND PROFILE
RA CAPITAL MANAGEMENT, L.P..
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 72Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$9760.9T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | ASND | ASCENDIS PHARMA A/S - ADR | 10.28M | $2192.4T | 22.5% | NEW |
| 2 | CDTX | CIDARA THERAPEUTICS INC | 3.37M | $743.4T | 7.6% | NEW |
| 3 | RYTM | RHYTHM PHARMACEUTICALS INC | 6.67M | $713.6T | 7.3% | NEW |
| 4 | RNAGBP | AVIDITY BIOSCIENCES INC | 8.64M | $623.3T | 6.4% | NEW |
| 5 | PCVX | VAXCYTE INC | 10.72M | $494.8T | 5.1% | NEW |
| 6 | SION | SIONNA THERAPEUTICS INC | 9.91M | $407.5T | 4.2% | NEW |
| 7 | NAMS | NEWAMSTERDAM PHARMA CO NV | 9.55M | $335.0T | 3.4% | NEW |
| 8 | TYRA | TYRA BIOSCIENCES INC | 12.20M | $320.7T | 3.3% | NEW |
| 9 | WVE | WAVE LIFE SCIENCES LTD | 18.20M | $309.5T | 3.2% | NEW |
| 10 | MLYS | MINERALYS THERAPEUTICS INC | 7.32M | $265.8T | 2.7% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE RA SIGNAL
AC read
RA CAPITAL MANAGEMENT, L.P. is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed